Citation & Authors
Front Immunol. 2025;16:1620768.
ABSTRACT · CHINESE TRANSLATION
Translated abstract
Translated from the licensed abstract via the Chinese version. This is not an official journal translation.
purpose
Psoriasis is associated with systemic inflammation and immune dysregulation, prompting interest in a potential association with antiphospholipid syndrome (APS). However, evidence on this risk remains limited.
Materials and methods
This retrospective cohort study used TriNetX US Collaborative Network data from 2002–2022. Demographics, comorbidities, and medication use were balanced between patients with and without psoriasis using 1:1 propensity score matching, yielding 288,678 patients per group. Univariable Cox proportional hazards models and subgroup analyses estimated hazard ratios for APS, and Kaplan–Meier methods generated cumulative incidence curves.
result
After matching, each cohort included 288,678 patients. APS occurred significantly more often in patients with psoriasis (1,349 cases versus 673 in controls; HR 1.71; 95% CI 1.56–1.88). Risk was further increased in those with concomitant psoriatic arthritis (1.91; 1.58–2.31). Subgroup analyses indicated greater susceptibility to APS in older patients, women, Black/African American patients, and those with chronic comorbidities.
Conclusion
Psoriasis and psoriatic arthritis were significant risk factors for APS, highlighting the need for targeted screening and management strategies in these populations.
Original work: Author of the above paper. Source:Public Summary ↗. This translation is based on the Chinese rendering of the original English abstract.
Original work license:CC BY ↗;Translations are subject to the same licensing conditions.
